Fennec Pharmaceuticals Says Cash And Cash Equivalents Of $12.4M Million Will Be Sufficient To Fund Our Planned Operations For At Least The Next Twelve Months
Portfolio Pulse from Benzinga Newsdesk
Fennec Pharmaceuticals has announced that its cash and cash equivalents of $12.4 million will be sufficient to fund its planned operations for at least the next twelve months.
November 06, 2023 | 11:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Fennec Pharmaceuticals' financial position is stable with enough cash to fund operations for the next year.
The announcement indicates a strong financial position for Fennec Pharmaceuticals, which is likely to instill confidence in investors and could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100